RWA
PFE icon

Redhawk Wealth Advisors’s Pfizer PFE Stock Holding History

Redhawk Wealth Advisors’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
46,808
-3,139
-6% -$82.1K 0.11% 168
2026
Q1 		$1.4M Sell
49,947
-1,858
-4% -$49.5K 0.15% 146
2025
Q4 		$1.29M Sell
51,805
-1,131
-2% -$28.5K 0.14% 142
2025
Q3 		$1.35M Buy
52,936
+5,439
+11% +$134K 0.16% 126
2025
Q2 		$1.15M Buy
+47,497
New +$1.11M 0.14% 134
2025
Q1 		– Sell
-7,971
Closed -$211K – 323
2024
Q4 		$211K Sell
7,971
-895
-10% -$24.3K 0.03% 279
2024
Q3 		$257K Sell
8,866
-1,430
-14% -$41.7K 0.04% 259
2024
Q2 		$288K Sell
10,296
-197
-2% -$5.42K 0.04% 231
2024
Q1 		$291K Sell
10,493
-416
-4% -$11.5K 0.05% 254
2023
Q4 		$314K Buy
10,909
+538
+5% +$16.3K 0.06% 217
2023
Q3 		$344K Buy
10,371
+1,682
+19% +$59.5K 0.11% 146
2023
Q2 		$319K Buy
8,689
+3,169
+57% +$123K 0.1% 150
2023
Q1 		$225K Sell
5,520
-14,608
-73% -$631K 0.08% 161
2022
Q4 		$1.03M Buy
20,128
+14,970
+290% +$718K 0.4% 75
2022
Q3 		$226K Buy
5,158
+81
+2% +$3.94K 0.1% 143
2022
Q2 		$266K Sell
5,077
-140
-3% -$7.13K 0.12% 135
2022
Q1 		$270K Sell
5,217
-3,182
-38% -$165K 0.07% 171
2021
Q4 		$496K Buy
8,399
+797
+10% +$39.5K 0.13% 115
2021
Q3 		$327K Sell
7,602
-3,850
-34% -$171K 0.09% 158
2021
Q2 		$448K Buy
11,452
+2,913
+34% +$113K 0.1% 154
2021
Q1 		$309K Sell
8,539
-4,142
-33% -$147K 0.08% 170
2020
Q4 		$467K Buy
12,681
+4,555
+56% +$167K 0.12% 128
2020
Q3 		$283K Buy
8,126
+293
+4% +$10.3K 0.08% 171
2020
Q2 		$243K Buy
+7,833
New +$266K 0.08% 158
2019
Q3 		– Sell
-4,429
Closed -$182K – 348
2019
Q2 		$182K Buy
+4,429
New +$176K 0.07% 145

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Redhawk Wealth Advisors's PFE Position: Q2 2026 in Review

Redhawk Wealth Advisors reduced its Pfizer (PFE) stake by 6.3% in Q2 2026, selling an estimated $82.1K and leaving 46,808 shares worth $1.13M. The position accounts for 0.11% of the portfolio, ranked #168.

Redhawk Wealth Advisors first reported a position in PFE in Q2 2019 and has held it in 25 quarters since. The position peaked at $1.4M in Q1 2026. 557 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Redhawk Wealth Advisors held 46,808 shares of Pfizer worth $1.13M as of Q2 2026.
  • Redhawk Wealth Advisors sold 3,139 Pfizer shares in Q2 2026, an estimated $82.1K.
  • Pfizer made up 0.11% of Redhawk Wealth Advisors's portfolio in Q2 2026, its #168 holding.
  • Redhawk Wealth Advisors first reported a position in Pfizer in Q2 2019 and has held it in 25 quarters since.
  • Redhawk Wealth Advisors's Pfizer position peaked at $1.4M in Q1 2026.
  • 557 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Redhawk Wealth Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.